Compare Gilead Sciences, Inc. (GILD) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Western Union Co — how do they compare? Gilead Sciences, Inc. trades at $135.47 (market cap $168.35B), while Western Union Co trades at $7.07 (market cap $2.20B). The key difference: Gilead Sciences, Inc. is far larger — about 76.5× Western Union Co's market cap, and Western Union Co pays the higher dividend (13.33%). Which is the better fit depends on your goals.
| GILD | WU | |
|---|---|---|
Market Cap | $168.35B | $2.20B |
Sector | Health | Technology |
52-Week High | $155.80 | $10.28 |
52-Week Low | $110.56 | $6.36 |
Enterprise Value | $191.42B | $2.10B |
Dividend Yield | 2.42% | 13.33% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
